| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 113.724 | 77 |
| GSM780708 | Untreated after 4 days (C2_1) | 87.5527 | 73 |
| GSM780709 | Untreated after 4 days (C3_1) | 130.772 | 79 |
| GSM780719 | Untreated after 4 days (C1_2) | 108.567 | 76 |
| GSM780720 | Untreated after 4 days (C2_2) | 98.4072 | 75 |
| GSM780721 | Untreated after 4 days (C3_2) | 125.013 | 78 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 94.0613 | 74 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 125.526 | 78 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 102.541 | 76 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 97.5036 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 113.033 | 77 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 99.1652 | 75 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 155.507 | 81 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 92.8007 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 105.649 | 76 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 152.75 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 99.97 | 75 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 108.86 | 76 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 109.772 | 77 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 147.21 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 110.162 | 77 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 119.18 | 78 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 98.1226 | 75 |